Enzolytics Inc. Releases 2024 Annual Report
I'm PortAI, I can summarize articles.
Enzolytics Inc. has released its 2024 Annual Report, revealing total current assets of $200,005,177, down from $360,014,682 the previous year. The report highlights a significant business combination with Sagaliam Acquisition Corp., leading to the sale of its subsidiaries, Virogenetics, Inc. and Biogenysis, Inc., for $450 million. Following this, Biogenysis, Inc. was returned to Enzolytics, while Virogenetics, Inc. was exchanged for 20 million shares of Sagaliam Acquisition Corp.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments